Journal
VOX SANGUINIS
Volume 108, Issue 1, Pages 27-36Publisher
WILEY
DOI: 10.1111/vox.12190
Keywords
cytokines; leucocyte antibodies; lysophospholipids; microparticles; pulmonary post-transfusion reactions
Categories
Funding
- Ministry of Science and Higher Education (Poland) [NN 401215734]
Ask authors/readers for more resources
Background and ObjectivesPost-transfusion reactions with dyspnoea (PTR) are major causes of morbidity and death after blood transfusion. Transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO) are most dangerous, while transfusion-associated dyspnoea (TAD) is a milder respiratory distress. We investigated blood components for immune and non-immune factors implicated in PTR. Material and MethodsWe analysed 464 blood components (RBCs, PLTs, L-PLTs, FFP) transfused to 271 patients with PTR. Blood components were evaluated for 1/antileucocyte antibodies, 2/cytokines: IL-1, IL-6, IL-8, TNF-, sCD40L, 3/lysophosphatidylcholines (LysoPCs), 4/microparticles (MPs) shed from plateletes (PMPs), erythrocytes (EMPs) and leucocytes (LMPs). ResultsAnti-HLA class I/II antibodies or granulocyte-reactive anti-HLA antibodies were detected in 182% of blood components (RBC and FFP) transfused to TRALI and in 05% of FFP transfused to TAD cases. Cytokines and LysoPCs concentrations in blood components transfused to PTR patients did not exceed those in blood components transfused to patients with no PTR. Only EMPs percentage in RBCs transfused to patients with TRALI was significantly higher (P<005) than in RBCs transfused to patients with no PTR. ConclusionImmune character of PTR was confirmed mainly in 1/5 TRALI cases. Among non-immune factors, only MPs released from stored RBCs are suggested as potential mediators of TRALI. Our results require further observations in a more numerous and better defined group of patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available